Virtus LifeSci Biotech Clinical Trials ETF
Health/Biotechnology
BBC
31 West 52nd Street,16th Floor
New York , NY, 10019
New York , NY, 10019
Price
-
$ 25.26
0 %
+0.31
Jun 28, 2024
- Last Close
- Net Assets
-
$10.1M
Mar 28, 2024
- 52-Week High/Low
- $31.35 - $16.88
- Expense Ratio
- -
Link
Directors
Jan 16, 2024- Robert S. Tull, Jr.
- William J. Smalley
- Myles J. Edwards
- James A. Simpson
Chief Compliance Officer
- Timothy Branigan
Company Name |
Holding |
| More | 0.85 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | 19.1% | -12.3% | -27.5% | 3.6% | -23% | 22.6% |
| Q2 | -4% | 9.3% | -22.7% | -2.8% | 47.4% | -0.6% |
| Q3 | - | -18.1% | 13.8% | -8.5% | -9.8% | -18.3% |
| Q4 | - | 29.8% | 1.7% | -15.7% | 27.2% | 59.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.8% | 18.5% | -3.1% | -10.4% | -1.1% | - | - | - | - | - | - | - |
| 2023 | 10.6% | -9.6% | -12.3% | 5% | 5.7% | -1.5% | 0.5% | -10.9% | -8.6% | -9% | 9.9% | 24.6% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.9% | -2.2% | -35.1% | -22.3% | 30.4% | 63.7% | -18.3% | 56.1% | -36.6% | 5.3% | -39.4% |